Inflammatory Pseudotumor of the Spleen: Review of clinical presentation and diagnostic methods

Por Yarmohammadi, Hooman, Nakamoto, Dean, Faulhaber, Peter F., Miedler, John, Azar, Nami
Publicado em 2011

Hybrid PET/MR imaging in two sarcoma patients – clinical benefits and implications for future trials

Por Partovi, Sasan, Kohan, Andres A, Zipp, Lisa, Faulhaber, Peter, Kosmas, Christos, Ros, Pablo R, Robbin, Mark R
Publicado em 2014

(18)FDG-PET/CT Definition of Clinical Target Volume for Robotic Stereotactic Body Radiosurgery Treatment of Metastatic Gynecologic Malignancies

Por Kunos, Charles A., Debernardo, Robert, Fabien, Jeffrey, Dobbins, Donald C., Zhang, Yuxia, Brindle, James, Faulhaber, Peter F.
Publicado no J Nucl Med Radiat Ther (2011)

Comparison of Standardized Uptake Values in Normal Structures Between PET/CT and PET/ MRI in an Oncology Patient Population

Por Kershah, Sharif, Partovi, Sasan, Traughber, Bryan J, Muzic, Raymond F., Schluchter, Mark D, O’Donnell, James K, Faulhaber, Peter
Publicado no Mol Imaging Biol (2013)

Role of FDG‐PET/MRI, FDG‐PET/CT, and Dynamic Susceptibility Contrast Perfusion MRI in Differentiating Radiation Necrosis from Tumor Recurrence in Glioblastomas

Por Hojjati, Mojgan, Badve, Chaitra, Garg, Vasant, Tatsuoka, Curtis, Rogers, Lisa, Sloan, Andrew, Faulhaber, Peter, Ros, Pablo R., Wolansky, Leo J.
Publicado no J Neuroimaging (2017)

Uptake of (18)F-Labeled 6-Fluoro-6-Deoxy-d-Glucose by Skeletal Muscle Is Responsive to Insulin Stimulation

Por Spring-Robinson, Chandra, Chandramouli, Visvanathan, Schumann, William C., Faulhaber, Peter F., Wang, Yanming, Wu, Chunying, Ismail-Beigi, Faramarz, Muzic, Raymond F.
Publicado em 2009

Image quality assessment of automatic three-segment MR attenuation correction vs. CT attenuation correction

Por Partovi, Sasan, Kohan, Andres, Gaeta, Chiara, Rubbert, Christian, Vercher-Conejero, Jose L, Jones, Robert S, O’Donnell, James K, Wojtylak, Patrick, Faulhaber, Peter
Publicado em 2013

Radiochemotherapy plus 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (3-AP, NSC #663249) in Advanced-Stage Cervical and Vaginal Cancers

Por Kunos, Charles A., Radivoyevitch, Tomas, Waggoner, Steven, Debernardo, Robert, Zanotti, Kristine, Resnick, Kimberly, Fusco, Nancy, Adams, Ramon, Redline, Raymond, Faulhaber, Peter, Dowlati, Afshin
Publicado no Gynecol Oncol (2013)

Diagnostic performance of an automated analysis software for the diagnosis of Alzheimer’s dementia with (18)F FDG PET

Por Partovi, Sasan, Yuh, Roger, Pirozzi, Sara, Lu, Ziang, Couturier, Spencer, Grosse, Ulrich, Schluchter, Mark D, Nelson, Aaron, Jones, Robert, O’Donnell, James K, Faulhaber, Peter
Publicado no Am J Nucl Med Mol Imaging (2017)

WHAT IS THE BEST WAY TO CONTOUR LUNG TUMORS ON PET SCANS:MULTI-OBSERVER VALIDATION OF A GRADIENT-BASED METHOD USING A NSCLC DIGITAL PET PHANTOM

Por Werner-Wasik, Maria, Nelson, Arden D., Choi, Walter, Arai, Yoshio, Faulhaber, Peter F., Kang, Patrick, Almeida, Fabio D., Xiao, Ying, Ohri, Nitin, Brockway, Kristin D., Piper, Jonathan W., Nelson, Aaron S.
Publicado em 2011

Clinical oncologic applications of PET/MRI: a new horizon

Por Partovi, Sasan, Kohan, Andres, Rubbert, Christian, Vercher-Conejero, Jose Luis, Gaeta, Chiara, Yuh, Roger, Zipp, Lisa, Herrmann, Karin A, Robbin, Mark R, Lee, Zhenghong, Muzic, Raymond F, Faulhaber, Peter, Ros, Pablo R
Publicado em 2014